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ABSTRACT
Background We examine the population impact on
functional disability and social participation of physical
and mental chronic conditions individually and in
combination.
Methods Cross-sectional, population-based data from
community-dwelling people aged 45 years and over
living in the 10 Canadian provinces in 2008–2009 were
used to estimate the population attributable risk (PAR)
for functional disability in basic (ADL) and instrumental
(IADL) activities of daily living and social participation
restrictions for individual and combinations of chronic
conditions, stratified by age and gender, after adjusting
for confounding variables.
Results Five chronic conditions (arthritis, depression,
diabetes, heart disease and eye disease) made the
largest contributions to ADL-related and IADL-related
functional disability and social participation restrictions,
with variation in magnitude and ranking by age and
gender. While arthritis was consistently associated with
higher PARs across gender and most age groups,
depression, alone and in combination with the physical
chronic conditions, was associated with ADL and IADL
disability as well as social participation restrictions in the
younger age groups, especially among women.
Compared to women, the combinations of conditions
associated with higher PARs in men more often included
heart disease and diabetes.
Conclusions Our findings suggest that in community-
dwelling middle-aged and older adults, the impact of
combinations of mental and physical chronic conditions
on functional disability and social participation restriction
is substantial and differed by gender and age.
Recognising the differences in the drivers of PAR by
gender and age group will ultimately increase the
efficiency of clinical and public health interventions.
INTRODUCTION
Many older North Americans live with multiple
chronic health conditions. In a study of over 650 000
patients in the USA, over 50% of patients aged
45–64 years, over 75% of patients aged 65–84 years
and almost 90% of patients aged 85 years or older
have two or more chronic conditions,1 with similar
trends in Canada.2 Increasing longevity and the
demographic shift to a higher proportion of the
population over the age of 65 years represents a new
challenge for healthcare systems in North America
and around the world.3 Multimorbidity, the coexist-
ence of two or more chronic conditions, where one
is not necessarily more central than the others,4 often
has a significant impact on older adults’ daily and
social activities5 and has been increasingly recognised
as an independent risk factor for decreased quality of
life,6 increased functional disability7 and premature
mortality.8
Despite the significant increase in the number of
publications addressing the subject, there is still no
standard definition for multimorbidity. The European
General Practice Research Network (EGPRN) sug-
gested the following definition: “any combination of
chronic disease with at least one other disease (acute
or chronic) or biopsychosocial factor (associated or
not) or somatic risk factor”.9 In this definition, a
biopsychosocial factor can be any biological, psycho-
logical or social factor that plays a role in the disease
process.10 This definition is in line with much of the
clinical thinking that multimorbidity must also take
into context patient complexity as chronic disease
management is substantially more complex when
individuals have multimorbidity.11 While it is gener-
ally agreed that patient-centred healthcare is most
likely the most effective and efficient mechanism to
optimise their health and well-being,4 clinicians often
struggle with the application of disease-specific guide-
lines to their older patients with multiple chronic con-
ditions, especially when they have both mental and
physical chronic conditions.12
Until now, few studies have examined multiple
chronic conditions and their impact on disability. In
previous work, it was found that among older adults
the chronic conditions that drive functional disability
differed by gender and age;7 however, this study did
not include mental health conditions. There is cur-
rently little research combining both physical and
mental chronic conditions, as suggested by the
EGPRN. To help consolidate this literature and
provide evidence-based data for clinical practitioners,
we have examined the population attributable risk
(PAR) for functional disability associated with physical
and mental chronic conditions, alone and in combin-
ation using population-based data from the Canadian
Community Health Survey (CCHS) on Healthy
Ageing.13 These comparisons were conducted using
the full spectrum of adults’ activities, that is, activities
of daily living (ADL), instrumental activities of daily
living (IADL) and social participation.
METHODS
Study population
The CCHS-Healthy Ageing is a cross-sectional
survey providing information about the health,
health determinants and healthcare use of
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community-dwelling people aged 45 years and over living in the
10 Canadian provinces.13 To maximise efficiency, a three-stage
design was used to select the sample, with random sampling of
geographical regions, then households within region, and finally
one respondent within a household. Sample weights were calcu-
lated based on the complex sampling design such that estimates
produced are representative of the target population. Data collec-
tion took place in participants’ homes from December 2008
through November 2009 using computer-assisted personal inter-
viewing. The content of the CCHS-Healthy Ageing was devel-
oped collaboratively by Statistics Canada and researchers from
the Canadian Longitudinal Study on Ageing (CLSA). As part of
the Statistics Canada-CLSA collaboration, CCHS participants
were asked to provide consent that their survey data could be
shared with the CLSA. This article includes data from CCHS par-
ticipants between the ages of 45 and 85 years, who consented to
share their data with the CLSA, henceforth referred to as the
CCHS-CLSA sample. Separate weights were constructed for the
CCHS-CLSA sample; thus, these data comprise a nationally rep-
resentative sample of community-living Canadian residents.
Functional disability in ADL and IADL
The measure of functional status was adapted from the ADL
section of part A of the Older Americans Resources and
Services Multidimensional Functional Assessment Questionnaire
(OMFAQ) (eTable 1). The OMFAQ contains 14 items pertain-
ing to functional disability in basic ADL and IADL, answered on
a six-point scale ranging from 1 (excellent functioning) to 6
(functioning totally impaired). For comparison with previous
work,7 functional disability was operationalised using two
dichotomous variables indicating a need for help with, or an
inability to perform, one or more of the (1) seven basic ADL
tasks, or (2) seven IADL activities.
Social participation restriction
During the ageing process, the inability to perform activities at a
societal level can be the first manifestation of the loss of inde-
pendence (eTable 1).14 Respondents were asked how often in
the past 12 months they participated in eight different
community-related activities. After completing the sections, par-
ticipants were asked whether or not they had felt they wanted
to participate in more activities and, if so, what prevented them
from doing so. Social participation restriction was operationa-
lised as: not participating as one desired because of limitations
due to health conditions.
Chronic conditions
Eleven chronic medical conditions were identified a priori as
putative risk factors for functional disability: heart disease,
stroke, diabetes, respiratory disease, hearing impairment, eye
disease, arthritis, depression, cognitive impairment, dementia
and Parkinson’s disease (eTable 1). Other than cognitive impair-
ment, hearing impairment and depression, all chronic condi-
tions were based on self-report of ‘long-term conditions’ which
were expected to last, or had already lasted, 6 months or more
and had been diagnosed by a health professional.
Hearing impairment was determined using the Health
Utilities Index hearing domain.15 Depression was measured
using a shortened version of the WHO Composite International
Diagnostic Interview Scale.16 The Mental Alternation Test17
(MAT), which measures executive function, was used to identify
people at greatest risk of cognitive impairment. This was per-
formed using a validated cut point of an age-standardised, sex-
standardised and education-standardised MAT score.18
Cognitive measures were not available for proxy respondents,
which is why proxy respondents were not included in the
current analyses.
It was reasoned that chronic conditions that were both preva-
lent and independently associated with both ADL and IADL
would be the most relevant from a public health and clinical
perspective, that is, associated with a higher PAR. Chronic con-
ditions for the PAR analysis were selected if they were present
in at least 10% of the population and had a statistically signifi-
cant relationship to functional disability (ADL or IADL) and
social participation restriction. Since including mental health
conditions was a focus of this study, we also included depression
despite the maximum prevalence of 8.7% across the age-sex
strata. A summary of excluded chronic conditions and their
association with disability and social restriction is included in
eTable 2.
Potential effect modifying and confounding variables
Since it has been shown that trajectories of disability and the
chronic conditions associated with functional disability differ by
age and gender,7 all analyses were stratified by age category (45–
54, 55–64, 65–74 and 75–85) and gender (eTable 1). Other
factors associated with functional disability and social participa-
tion that could be potential confounders included: living alone,
ethnicity, body mass index and socioeconomic status (SES).19
SES was operationalised using a relative measure of household
income to household income of all other respondents in the
same province.20
Statistical analysis
A PAR represents the proportion of cases of a health outcome
that would not occur in a population if a particular risk factor
were eliminated. From a population health perspective, it is also
relevant to examine the PAR of combinations of conditions as
well as a single condition, for example, estimating the propor-
tion of ADL disability that will not occur if arthritis and dia-
betes were eliminated. The PAR for a combination of chronic
conditions is not simply the sum of the PARs for the individual
conditions. Part of the reason for this is that chronic conditions
are generally not mutually exclusive. In our examples, there may
be some people with arthritis but not diabetes, some people
with diabetes but not arthritis, but there will also be some
people with both. Therefore, the prevalence of arthritis or dia-
betes will be less than the summed prevalence of each
condition.
The method proposed by Basu and Landis21 was used to
explore the population impact of selected chronic conditions
on functional disability and social participation restriction,
while adjusting for other chronic conditions and relevant cov-
ariates. In a population with significant levels of multimorbid-
ity, it is critical to adjust for the effect of other comorbid
conditions when estimating the PAR for a specific chronic con-
dition. For each age-sex stratum, the PAR for single conditions
and combinations of chronic conditions and their 95% CIs
were estimated based on a series of unconditional multivariable
logistic regression models using interactive risk attributable
program software (US National Cancer Institute, 2002). Owing
to the complex design used by the CCHS,22 prevalence esti-
mates used in the PAR calculation had to be adjusted using the
sampling weights. Bootstrap methods were applied to obtain
1000 estimates from which appropriate non-parametric CIs
were calculated.23




Of the 26 087 CCHS-CLSA participants, 18 553 (71.1%) com-
pleted the main survey and the cognition component. Of those,
15 799 (78.7%) had complete ADL, IADL, social participation
and chronic conditions. The included participants tended to be
slightly younger, more often men and have higher education
and income (p<0.05).18 The mean age of included participants
was 63.6±10.3 years, 94.0% were white, 53.7% were women,
31.6% lived alone and the median household income was
$50 000 CDN (data not shown).
Table 1 presents the proportion of participants with each
chronic condition, ADL and IADL disability, and social participa-
tion restriction, overall and by age and sex strata. Overall, the
prevalence of functional disability in ADL was 6.5% in men and
12.8% in women, IADL disability was 3.6% for men and 8.6%
for women. The most common ADL and IADL limitation was
trouble getting to the toilet on time and doing housework,
respectively (data not shown). Social participation restriction was
reported by 4.8% of men and 6.7% of women. A statistically sig-
nificant increase in prevalence of ADL and IADL disability and
social participation restriction was found with age (table 1). Eight
of the 11 chronic conditions had a prevalence >10%, arthritis
being the most common with a prevalence up to 55.5% in
women aged 75–85, and were significantly related to functional
disability or social participation restriction for at least one age-
gender stratum (heart disease, diabetes, respiratory disease,
hearing impairment, eye disease, arthritis, depression and cogni-
tive impairment). These conditions were included in the
PAR analyses. Although well below 10%, there was a strong
association between the remaining three chronic conditions
(Alzheimer’s disease, Parkinson’s disease and stroke) with func-
tional disability and social participation restriction (eTable 2).
PARs for ADL disability
Table 2 presents the highest PARs by age and sex for ADL dis-
ability associated with single and combinations of two and three
chronic conditions. For the younger age groups, men generally
had higher PARs compared to women, but this trend reversed
for the older age groups. Overall, the presence of arthritis, dia-
betes, eye disease, heart disease and depression contributed the
most to PAR in ADL-related disability. For men, heart disease
and arthritis were associated with the largest PARs in the
younger age groups while diabetes, arthritis and eye disease,
alone and in combination, were associated with higher PARs in
the older age groups. In women, depression tended to be a
stronger driver of ADL-related disability in the younger age
groups, while arthritis, diabetes, respiratory disease and eye
disease were associated with larger PARs in the older age
groups. Compared to men, women less frequently had heart
disease as a major contributor to the largest PARs for disability,
but rather arthritis. In most cases, the chronic conditions with
the highest PARs when considered alone were also represented
in the combinations of chronic conditions with the highest
PARs.
PARs for IADL disability
The PARs for chronic conditions associated with IADL disability
tended to be higher than those for ADL disability (table 3). The
magnitude of the PARs was similar for men and women in the
youngest and oldest age groups, but higher for women between
the ages of 55–74 years. Overall, arthritis, heart disease and
respiratory disease were associated with the highest PARs across
most age groups. However, depression had the second largest
PAR for women in the two youngest age groups.
PARs for social participation restriction
The PARs for social participation restriction tended to be
similar in magnitude to those for IADL disability (table 4). With
the exception of men aged 75–85, arthritis had the highest PAR
for social participation restriction for all age-gender strata. For
both men and women, depression was a strong driver of the
PAR for the younger age groups and diabetes in the older age
groups. Similar to ADL disability, eye disease did not have the
highest PAR, but contributed to many of the triplets.
DISCUSSION
This study demonstrated that physical and mental chronic con-
ditions, alone and in combination, were strongly associated with
functional disability and social participation restriction. In
males, the PARs associated with combinations of three chronic
conditions were generally over 30 and up to 57 for social par-
ticipation restriction. In women, the magnitude of the PARs
varied more but the highest PAR for a combination of three
chronic conditions was also for social participation restriction,
70.9. In younger women, depression, alone and in combination
with the physical chronic conditions such as arthritis, was com-
monly associated with ADL and IADL disability as well as social
participation restrictions. Compared to women, the combina-
tions of conditions associated with higher PARs in men more
often included ischaemic heart disease (IHD) and diabetes. For
both men and women and across all age groups, arthritis, alone
and in combination with other chronic conditions, was consist-
ently associated with high PARs for functional disability and
social participation restrictions. In most cases, the conditions
with the highest individual PARs were also represented in the
combination of chronic conditions with highest PARs. Many of
the triplets represented conditions that impact different organ
systems.
The current study is unique in that we examine the drivers of
functional disability in younger age groups, that is, 45–54 years.
We found in the younger age groups that depression and arth-
ritis were most often associated with the highest PARs for func-
tional disability, especially in women. This finding is supported
by data from the National Health Interview Survey where in
40–64 year-olds, arthritis and depression were ranked two and
three (following back and neck pain) as conditions that caused
one to need help with ADLs and IADLs, whereas depression
was not in the top 10 chronic conditions associated with func-
tional limitations in people over 65 years of age.24 The authors
did not report the data for men and women separately, but our
results suggest that depression may be more prevalent and more
highly associated with functional disability in women compared
to men in the younger age groups.
Unlike previous work,7 we found that the PARs associated
chronic conditions for IADL disability tended to be higher than
those for ADL disability and did not find a strong association
with cognitive impairment. These findings may be explained by
differences in the time period of the data sources and popula-
tions studied. The prior analysis included a population-based
sample of Canadians aged 65 years and older which was con-
ducted 25 years ago. This paper includes similar population-
based data including people aged 45–85 years recruited in
2007/2008. Recent data indicate that in people aged 40–64
years, there has been a significant increase in IADL limitations,
especially among women; however, the rates have remained the
same or decreased in those aged 65 years or older,24 which may
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Other topics
explain our cohort effect. Compared to previous work, we also
found little relationship between cognitive impairment and
functional limitations. In the previous study, cognitive impair-
ment was primarily a driver for functional disability PARs
related to the subset of complex self-management tasks (inability
to handle money, use the phone or self-medicate). In the
CCHS-CLSA population, the prevalence of complex self-
management disability among the age-gender groups ranged
from 0.2% to 5%, and thus we did not have sufficient power to
look at this outcome separately.
In this paper, we examined PARs for functional disability, as
well as for social participation restriction. Epidemiological
studies suggest that social activities are particularly important
for older adults25 and the WHO recognises the ability to partici-
pate in societal activities as one of the direct consequences of
health;26 thus, social participation has been integrated into
research and policy frameworks of ageing. We found that the
combinations of chronic conditions that had an impact on func-
tional disability, especially in IADLs, also impacted social partici-
pation. This is consistent with the literature as greater disability
can restrict social participation.27 In fact, disability has been
found to be one of the most powerful determinants of social
participation.28 These findings are particularly important as
social participation restriction is associated with social isolation
and frailty.7 29
This study draws on a large-scale national population-based
sample that has a high response rate using a multicausal model-
based estimation of PAR. Compared with previous investiga-
tions, we were able to estimate PARs associated with various
combinations of chronic conditions (both mental and physical
conditions) while controlling for other comorbid conditions and
potential confounding factors. Single condition PARs are typic-
ally overestimated from the population where multimorbidity
exists. The reason is that the number of events that occur for
subjects having two or more exposures are counted ‘double’
when the PAR is calculated for one exposure only. The large
sample size allowed us to examine the independent effect of
single and combinations of chronic conditions while adjusting
for the others.
Our study has some limitations. First, there is the issue of the
accuracy of self-reported medical conditions in large-scale com-
munity surveys. Although we have not been able to examine
physician-diagnosed conditions, self-reported diagnoses have
shown to be valid, reliable and are standard in epidemiological
research. Some conditions, such as foot problems and cancer,
that have been shown to be related to disability, were either not
measured in CCHS or not measured with sufficient detail to be
included in our analyses. Also, we chose to operationalise
depression using the adapted Composite International
Diagnostic Interview Scale.16 Other mental health conditions,
Table 2 Population attributable risk for activities of daily living disability by gender and age category
Males Females
Age group (years) 1 Condition 2 Conditions 3 Conditions 1 Condition 2 Conditions 3 Conditions
45–54 IHD
18.7 (5.4 to 32.4)
IHD+RES
25.3 (9.9 to 41.1)
IHD+RES+DIA
29.6 (11.9 to 45.0)
DEP
8.8 (1.8 to 15.7)
DEP+IHD
13.4 (5.5 to 21.9)
DEP+IHD+HER
14.4 (6.3 to 23.2)
RES
6.8 (−5.1 to 19.0)
IHD+DIA
24.0 (7.8 to 39.7)
IHD+RES+HER
27.9 (12.6 to 43.3)
IHD
4.6 (0.01 to 9.7)
DEP+HER
10.0 (2.7 to 17.5)
DEP+HER+ART
13.4 (2.5 to 23.3)
DIA
5.7 (−6.9 to 17.9)
HER
1.2 (−2.5 to 5.0)
HER
2.6 (−0.3 to 8.6)
ART
0.01 (−8.9 to 9.9)
55–64 ART
16.9 (4.7 to 28.1)
ART+IHD
28.2 (15.9 to 40.7)
ART+IHD+DIA
34.6 (21.6 to 47.0)
ART
12.2 (1.3 to 23.0)
ART+DEP
19.9 (8.6 to 29.7)
ART+DEP+EYE
24.9 (13.8 to 35.1)
IHD
14.5 (5.5 to 23.7)
ART+DIA
25.2 (12.4 to 37.8)
ART+IHD+RES
32.0 (19.4 to 44.1)
DEP
8.7 (3.8 to 13.4)
ART+EYE
17.5 (7.0 to 28.4)
ART+DEP+HER
21.3 (10.4 to 31.7)
DIA
10.0 (0.9 to 18.8)
EYE
6.1 (1.3 to 11.0)
RES
7.4 (−0.5 to 15.1)
HER
2.0 (−0.3 to 4.6)
65–74 DIA
18.2 (10.1 to 26.5)
DIA+COG
22.4 (12.4 to 31.4)
DIA+COG+EYE
23.9 (13.0 to 34.0)
ART
36.9 (25.5 to 47.7)
ART+DIA
48.6 (38.8 to 57.3)
ART+DIA+EYE
55.3 (46.5 to 63.0)
COG
4.9 (−1.4 to 11.7)
DIA+EYE
19.8 (9.3 to 29.2)
DIA+COG+ART
23.5 (9.7 to 36.3)
DIA
19.9 (13.3 to 26.5)
ART+EYE
45.6 (35.2 to 54.9)
ART+DIA+IHD
53.0 (43.8 to 61.0)
EYE
1.8 (−5.6 to 9.4)
EYE
13.0 (5.0 to 21.5)
ART
1.3 (−11.2 to 13.0)
IHD
10.4 (4.1 to 16.7)
75–85 DIA
13.6 (4.0 to 23.3)
DIA+ART
24.1 (8.6 to 39.0)
DIA+ART+EYE
30.9 (15.4 to 45.7)
ART
35.0 (23.8 to 45.9)
ART+RES
47.1 (37.1 to 56.9)
ART+RES+EYE
54.3 (44.2 to 63.9)
ART
12.4 (−3.9 to 28.5)
DIA+EYE
21.0 (6.2 to 35.3)
DIA+ART+IHD
30.4 (14.0 to 46.0)
RES
17.8 (11.2 to 24.0)
ART+EYE
44.1 (32.4 to 55.1)
ART+RES+DIA
51.4 (41.6 to 61.2)
EYE
8.6 (−3.8 to 21.3)
EYE
14.0 (3.7 to 23.3)
IHD
8.5 (−4.2 to 20.6)
IHD
8.1 (0.5 to 14.8)
DIA
7.6 (1.9 to 13.1)
Adjusted for: living alone (yes, no), adjusted total household income to the provincial low income cut-off (above median, below median), ethnicity (white, non-white), BMI (<25, 25–30,
>30), other comorbid conditions (any of Alzheimer’s disease, Parkinson’s disease or stroke).
ART, arthritis; BMI, body mass index; COG, cognitive impairment; DEP, depression; DIA, diabetes; EYE, eye disease; HER, hearing impairment; IHD, ischaemic heart disease; RES,
respiratory disease.
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such as anxiety, may also be related to disability and social par-
ticipation restriction. Since the anxiety module was not included
in the CCHS, we were not able to examine the potential impact
of anxiety. Second, although the sample was large, we did
restrict our analyses to participants with complete data. The
people with complete data tended to be slightly younger, more
often men and have higher education and income. In addition,
since proxy respondents were excluded, it could be that the
sample had slightly higher cognitive functioning. We have tried
to mitigate the impact of the bias that could be introduced by
stratifying our analyses by age and sex and by adjusting our esti-
mates for potential confounders, such as SES. This could,
however, limit our generalisability to community-living popula-
tions with higher levels of cognitive impairment.
Finally, the results generated from cross-sectional data need to
be interpreted with care, given that causal direction cannot be
definitive. While it is unlikely that functional disability causes
arthritis, it is less clear with conditions such as depression. In
fact, some of the associations examined are most likely bidirec-
tional. To address these limitations, it would be beneficial to
apply the PAR methodology to longitudinal data.
Implications for clinical and public health interventions
Knowing which chronic conditions are associated with greater
functional disability and social participation restriction may help
clinicians to target treatment strategies in patient populations.
Awareness of the PAR for single conditions and combinations of
conditions in different genders at different ages provides the
opportunity for more precise targeting. For example, the very
strong association among arthritis, functional disability and
social participation restriction, especially in older women, may
guide the physician towards more aggressive behavioural (eg,
exercise), physical, pharmacological and possibly surgical man-
agement in that patient population. Similarly, the association
among depression, functional disability and social participation
in younger middle-aged women may prompt the physician to
more carefully and systematically investigate for depressive
symptoms in this patient population. In the event that major
public health initiatives are directed towards specific conditions
(eg, osteoarthritis), physicians and other clinicians will have an
important role in disease management.
For policymakers, the PAR data for different demographic
groups may help to develop preventive health strategies which
Table 3 Population attributable risk for instrumental activities of daily living disability by gender and age category
Males Females
Age group (years) 1 Condition 2 Conditions 3 Conditions 1 Condition 2 Conditions 3 Conditions
45–54 ART
33.0 (−13.5 to 77.8)
ART+IHD
51.3 (−6.6 to 100)
ART+IHD+DEP
56.5 (1.2 to 100)
ART
36.4 (17.6 to 53.9)
ART+DEP
49.9 (33.4 to 66.1)
ART+DEP+RES
53.7 (37.4 to 69.1)
IHD
29.7 (−10.6 to 71.6)
ART+DIA
47.2 (−13.5 to 100)
ART+DEP+DIA
53.9 (0.9 to 100)
DEP
20.9 (4.4 to 35.9)
ART+RES
42.0 (24.7 to 58.6)
ART+DEP+IHD
51.3 (34.2 to 66.9)
DEP
26.3 (−5.1 to 58.5)
RES
6.5 (−11.9 to 23.8)
RES
21.5 (−16.3 to 62.5)
IHD
4.1 (−3.1 to 12.7)
DIA
19.0 (−13.1 to 60.0)
55–64 ART
22.4 (0.6 to 43.5)
ART+RES
36.5 (16.2 to 56.2)
ART+DIA+RES
45.1 (24.6 to 64.0)
ART
34.3 (20.2 to 48.0)
ART+DEP
47.0 (34.8 to 59.0)
ART+DEP+RES
51.6 (39.9 to 63.0)
DIA
19.2 (4.5 to 35.1)
ART+DIA
36.2 (14.2 to 55.8)
ART+DIA+DEP
43.8 (25.4 to 62.1)
DEP
18.0 (10.3 to 25.7)
ART+RES
40.1 (25.0 to 52.9)
ART+DEP+DIA
51.2 (39.0 to 62.3)
RES
18.8 (4.8 to 32.5)
RES
10.8 (2.1 to 19.8)
DEP
12.4 (1.7 to 24.3)
DIA
9.2 (0.7 to 17.3)
65–74 ART
26.6 (9.5 to 43.3)
ART+IHD
38.2 (19.7 to 54.0)
ART+IHD+DEP
46.0 (30.2 to 60.9)
ART
49.3 (37.7 to 59.8)
ART+DIA
60.4 (50.4 to 69.8)
ART+DIA+RES
68.0 (59.3 to 75.7)
IHD
16.7 (4.5 to 29.0)
ART+DEP
34.3 (18.5 to 50.1)
ART+IHD+COG
42.6 (23.9 to 58.2)
DIA
22.4 (13.7 to 30.8)
ART+RES
58.7 (48.7 to 68.0)
ART+DIA+RES
65.9 (56.8 to 74.2)
DEP
11.6 (4.5 to 19.1)
RES
14.2 (5.7 to 22.3)
COG
5.9 (−3.1 to 14.7)
EYE
13.6 (3.2 to 23.3)
75–85 EYE
26.8 (13.1 to 39.4)
EYE+IHD
43.1 (27.9 to 57.2)
EYE+IHD+DIA
51.1 (36.2 to 65.1)
ART
29.1 (16.5 to 40.0)
ART+IHD
38.7 (27.4 to 48.5)
ART+IHD+EYE
46.8 (35.0 to 56.8)
IHD
22.8 (9.7 to 36.8)
EYE+DIA
38.3 (24.0 to 52.0)
EYE+IHD+COG
50.5 (34.2 to 64.1)
EYE
13.6 (4.1 to 23.3)
ART+EYE
38.6 (25.6 to 50.0)
ART+IHD+RES
45.3 (35.0 to 54.2)
DIA
17.3 (6.5 to 28.8)
IHD
13.5 (6.9 to 20.0)
ART
14.0 (−4.5 to 31.1)
RES
10.8 (5.0 to 16.4)
HER
12.6 (2.4 to 22.8)
COG
10.6 (0.9 to 20.5)
Adjusted for: living alone (yes, no), adjusted total household income to the provincial low income cut-off (above median, below median), ethnicity (white, non-white), BMI (<25, 25–30,
>30), other comorbid conditions (any of Alzheimer’s disease, Parkinson’s disease or stroke).
ART, arthritis; BMI, body mass index; COG, cognitive impairment; DEP, depression; DIA, diabetes; EYE, eye disease; HER, hearing impairment; IHD, ischaemic heart disease; RES,
respiratory disease.
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Other topics
target individual conditions, as well as clusters of diseases which
share risk factors and together impact functional disability. Syed
et al describe an example of PAR being used to estimate the effect
of vascular risk factor reduction in the population of
Herefordshire (UK), population 182 441. Applying a nationally
developed vascular risk factor screening programme to all adults
aged 40–74 years, and instituting appropriate therapy would result
in a reduction of 90 myocardial infarction events, 63 coronary
heart disease events and 125 stroke events over 5 years.30 A mod-
elling study by Kite et al,31 based on the population of New South
Wales in Australia, used PAR and other tools to estimate the effects
of a sector wide intervention to reduce obesity. The strategy
involved dietary changes (reduction of energy dense, nutrient
poor food and drinks, increased consumption of fruits and vegeta-
bles), promotion of greater participation in sport and other vigor-
ous physical activity. In addition, societal changes would increase
participation in walking and bicycling, and attempts would be
made to move a greater percentage of the population closer to city
centres and use public transport instead of private vehicles. This
type of sector wide intervention would decrease the incidence of
arthritis, depression and cardiovascular disease. Such proposals are
ambitious and controversial, but knowledge of PAR for various
conditions and clusters of conditions provides a useful tool to esti-
mate the impact of these schemes.
PAR data from this study may inform at least two alternative
(but related) strategies to reduce disability at population level.
The first is a disease-specific strategy (eg, osteoarthritis), and the
second is aimed at reduction of common risk factors for mul-
tiple conditions (eg, arthritis, diabetes, heart disease, depres-
sion). Of the modifiable risk factors for osteoarthritis,
overweight/obesity, lack of exercise and joint injury are the most
easily identified,32 but significant challenges exist in implemen-
tation of, and adherence to, recommendations to avoid them.
Once established, symptoms of hip and knee OA are alleviated
by regular exercise,33–35 including walking,36 and there are
evidence-based non-pharmacological and pharmacological treat-
ments to relieve symptoms.37 As eye diseases become more
important drivers of disability in those over age 75 years,
regular assessments by eye care professionals can be recom-
mended, although screening in primary care for visual acuity is
not recommended by the USPSTF.38
For the common risk factor strategy, weight control, diet and
exercise have again emerged as important for both prevention
and treatment of osteoarthritis, ischaemic heart disease and type
2 diabetes. Furthermore, there is evidence that exercise reduces
the risk of developing depression,39 as well as being a moder-
ately effective treatment.40 Although population level risk factor
reduction is extremely challenging, it has been accomplished in
Table 4 Population attributable risk for social participation restriction by gender and age category
Males Females
Age group 1 Condition 2 Conditions 3 Conditions 1 Condition 2 Conditions 3 Conditions
45–54 ART
26.3 (7.3 to 44.1)
ART+DEP
39.6 (21.7 to 58.4)
ART+DEP+IHD
49.6 (31.1 to 69.8)
ART
33.4 (17.4 to 49.2)
ART+DEP
44.8 (30.9 to 58.0)
ART+DEP+EYE
52.8 (41.1 to 65.4)
DEP
22.6 (8.3 to 39.0)
ART+IHD
37.5 (16.7 to 56.6)
ART+DEP+EYE
43.9 (26.1 to 63.0)
DEP
20.9 (9.2 to 32.1)
ART+EYE
41.3 (26.1 to 56.9)
ART+DEP+RES
49.7 (35.7 to 63.0)
IHD
14.7 (−1.5 to 30.3)
RES
10.9 (−2.5 to 24.4)
EYE
7.8 (−1.3 to 19.5)
EYE
10.0 (2.9 to 17.9)
55–64 ART
21.9 (7.0 to 38.1)
ART+DEP
34.8 (21.5 to 47.9)
ART+DEP+DIA
43.4 (30.2 to 56.4)
ART
26.8 (13.4 to 40.0)
ART+DEP
36.3 (23.0 to 48.2)
ART+DEP+RES
43.5 (30.6 to 55.1)
DEP
18.5 (10.8 to 26.5)
ART+DIA
32.6 (17.6 to 47.2)
ART+DEP+IHD
42.8 (30.6 to 54.6)
DEP
13.0 (5.9 to 20.5)
ART+RES
34.6 (21.0 to 47.3)
ART+DEP+IHD
41.2 (29.1 to 52.8)
DIA
12.8 (3.7 to 22.4)
RES
11.3 (2.2 to 20.5)
IHD
11.0 (−0.1 to 21.5)
IHD
7.7 (0.2 to 15.3)
65–74 ART
18.3 (3.0 to 34.5)
ART+DIA
29.9 (12.1 to 44.9)
ART+DIA+IHD
36.5 (19.3 to 51.3)
ART
43.3 (28.5 to 59.3)
ART+DIA
59.2 (46.5 to 71.0)
ART+DIA+IHD
65.9 (54.8 to 76.4)
DIA
14.0 (2.6 to 26.1)
ART+IHD
26.4 (8.3 to 43.4)
ART+DIA+COG
32.4 (16.2 to 47.3)
DIA
25.1 (13.9 to 35.7)
ART+IHD
55.9 (42.0 to 68.7)
ART+DIA+EYE
62.7 (50.6 to 73.7)
IHD
9.7 (−3.4 to 22.1)
IHD
19.7 (10.9 to 29.1)
COG
3.3 (−5.4 to 11.6)
EYE
9.4 (−3.4 to 21.6)
75–85 DIA
30.2 (16.9 to 43.2)
DIA+ART
49.4 (30.4 to 64.8)
DIA+ART+EYE
57.0 (41.0 to 72.1)
ART
62.1 (49.1 to 74.8)
ART+IHD
69.3 (58.0 to 79.8)
ART+IHD+EYE
70.9 (59.4 to 81.8)
ART
28.9 (7.0 to 48.0)
DIA+EYE
41.0 (24.1 to 56.6)
DIA+ART+COG
52.2 (32.3 to 68.7)
IHD
16.6 (6.2 to 26.9)
ART+EYE
63.9 (49.8 to 76.8)
ART+IHD+HER
70.7 (59.8 to 81.1)
EYE
16.1 (−0.2 to 32.6)
EYE
5.1 (−10.7 to 19.7)
RES
6.3 (−4.9 to 16.5)
DEP
4.5 (0.4 to 8.9)
COG
4.6 (−7.3 to 15.9)
HER
4.4 (−1.9 to 11.9)
Adjusted for: living alone (yes, no), adjusted total household income to the provincial low income cut-off (above median, below median), ethnicity (white, non-white), BMI (<25, 25–30,
>30), other comorbid conditions (any of Alzheimer’s disease, Parkinson’s disease or stroke).
ART, arthritis; BMI, body mass index; COG, cognitive impairment; DEP, depression; DIA, diabetes; EYE, eye disease; HER, hearing impairment; IHD, ischaemic heart disease; RES,
respiratory disease.
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some jurisdictions including Finland.41 Using longitudinal
population-based data, it would be possible to estimate the
effect on functional disability in different demographic groups,
and even explore the cost-effectiveness of such strategies.
What is already known on this subject
▸ The association between single chronic conditions and
functional disability is well documented. However, there is
little research examining the combination of both physical
and mental chronic conditions or functional disability or on
social participation restriction.
What this study adds
▸ Our findings suggest that in community-dwelling older adults,
the impact of some mental and physical chronic conditions
on functional disability and social participation restrictions is
substantial. In combination, arthritis, ischaemic heart disease
or diabetes, and depression (especially in the younger age
groups) were most often related to disability and social
participation restrictions; however, the specific combinations
and the magnitude of the population attributable risk (PARs)
differed by gender and age. Such differences suggest that
interventions will be most efficient if they are tailored to
recognise the differences in the drivers of PAR by gender and
age group.
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